Pharmafile Logo

global access

- PMLiVE

Nutraceuticals: Big Pharma or Big Food’s next Big Growth area?

Evidence-based nutrition might seem a strong growth area for pharma but amidst the opportunities there are challenges…

- PMLiVE

Lilly acquires Alzheimer’s diagnostics from Siemens

Imaging agents to target tau tangles

Portland Health wins Mundipharma account

Handling communications for the pain, oncology and asthma specialist

- PMLiVE

FDA bars generic version of Purdue’s painkiller OxyContin

New abuse-deterrent formulation means original version no longer has positive benefit-to-risk profile

- PMLiVE

AbbVie said to be planning major salesforce cuts in US

Follows loss of patent protection for TriCor and Niaspan

- PMLiVE

Eisai appoints Lynn Kramer chief clinical officer

Says newly created position will strengthen its research base

- PMLiVE

OTC recovery helps J&J in first-quarter

Recalled products return to market to drive sales

- PMLiVE

Revamping the NHS and the challenges for pharma

As changes reshape England’s National Health Service, how should pharma engage with the new CCGs?

Roche - Basel

Roche taps local expertise for hep C drug in China

Partners with Chinese-American biotech company Ascletis

- PMLiVE

Royalty Pharma sweetens bid for Elan

Says new offer places $4.4bn value on Tysabri royalties

- PMLiVE

AstraZeneca signs cancer biomarkers discovery deal

Partners with UK firm on personalised oncology drug research

Astellas appoints Dr Songlin Xue head of global pharmacovigilance

He joins from Takeda and was formerly at Novartis and Wyeth

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links